[Stiff-man syndrome: an immunopathy?].
The discovery of autoimmune processes in the stiff-man syndrome (SMS) not only raises questions concerning the syndrome itself, but may also lead to new insights into pathogenetic principles of neurological disorders. Autoantibodies against GAD, the GABA synthesising enzyme, may become a helpful (though not specific) diagnostic tool, and furthermore may serve as a plausible explanation for both the symptoms of the syndrome and the delayed development of type I diabetes mellitus. However, it remains unexplained why autoimmunity against such widespread inhibitory transmitter systems should induce a syndrome which by definition is confined to only a few symptoms, and for which the majority of neurological signs are regarded as exclusion criteria. It is therefore hypothesised that SMS is part of a broad spectrum of encephalomyelopathies with autoimmunity against GABAergic neurones in common, but with a heterotopic manifestation. Progressive encephalomyelitis with rigidity may be an extreme variant within this spectrum.
Meinck
H M
HM
Sektion Klinische Neurophysiologie, Neurologische Universitätsklinik Heidelberg.
D001323:Autoantibodies / Q000032:analysis*; D001327:Autoimmune Diseases / Q000175:diagnosis / Q000276:immunology*; D005969:Glutamate Dehydrogenase / Q000276:immunology*; D006801:Humans; D009474:Neurons / Q000276:immunology; D016750:Stiff-Person Syndrome / Q000175:diagnosis / Q000276:immunology*; D005680:gamma-Aminobutyric Acid / Q000276:immunology*
D001323:Autoantibodies; D005680:gamma-Aminobutyric Acid; D005969:Glutamate Dehydrogenase
Das Stiff-man-Syndrom: eine Immunopathie?